- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
ARIAD Pharmaceuticals Inc+ Add to Watchlist
ARIA:US5.9000 USD 0.1600 2.64%
As of 20:10:00 ET on 08/21/2014.
Company Profile for ARIAD Pharmaceuticals Inc (ARIA)
ARIAD Pharmaceuticals, Inc. is a global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. The Company's approach to structure-based drug design has led to several molecularly targeted medicines for drug-resistant or difficult-to-treat cancers.
ARIAD Pharmaceuticals Inc
Key Executives for ARIAD Pharmaceuticals Inc (ARIA)
|Harvey J BergerChairman/President/CEO||Timothy P ClacksonChief Scientific Ofcr/Pres:R&D|
|Edward M FitzgeraldExec VP/CFO/Treasurer||Martin J Duvall "Marty"Exec VP/Chief Commercial Ofcr|
|Hugh M ColeSenior VP/Chief Business Ofcr||David L BersteinSenior VP/Chief Intellectual|
|Frank G HaluskaSenior VP/Chief Medical Ofcr||Maria E CantorSenior VP:Corporate Affairs|
|Daniel M BollagSenior VP:Regulatory Affairs|